{
    "Question": "Xenco Medical CES 2024 product highlight and specification",
    "Summary": "Xenco Medical\n\nProduct: TrabeculeX Continuum™\n\n- The TrabeculeX Continuum™ is the first technology-enabled bridge between orthobiologics and digital health, unifying a patient’s biomaterial implantation and postoperative journey.\n- Comprises the FDA-cleared TrabeculeX Bioactive Matrix™ and the TrabeculeX Recovery App™.\n- Empowers surgeons to enroll patients in the TrabeculeX Recovery App for Remote Therapeutic Monitoring and asynchronous video and text messaging.\n- Engineered to harness the hydroxycarbonate apatite-forming capabilities of bioglass in every TrabeculeX Bioactive Matrix, conducting three-dimensional bone formation.\n- The TrabeculeX Recovery App enables surgeons to remotely monitor patient-specific physical rehabilitation plans and engage in asynchronous video and text messaging.",
    "Summary_cn": "Xenco Medical\n\n产品：TrabeculeX Continuum™\n\n- TrabeculeX Continuum™是首个融合了骨科生物材料和数字健康技术的技术桥梁，统一了患者的生物材料植入和术后旅程。\n- 包括经FDA核准的TrabeculeX Bioactive Matrix™和TrabeculeX Recovery App™。\n- 赋予外科医生能力，使其能够将患者纳入TrabeculeX Recovery App进行远程治疗监测，并进行异步视频和文本消息交流。\n- 通过利用生物玻璃的羟基碳酸盐磷灰石形成能力，TrabeculeX Bioactive Matrix能够进行三维骨组织形成。\n- TrabeculeX Recovery App使外科医生能够远程监控患者特定的身体康复计划，并进行异步的视频和文本消息交流。"
}